FENC ▼ -0.1% - Fennec Pharmaceuticals Inc. $FENC - Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026 Fennec Pharmaceuticals shares fell 0.1% after the company announced it will present detailed results from a Phase 2 investigator-initiated study of its drug Pedmark in Japan at the SIOP 2026 conference. The modest decline suggests the market had limited immediate reaction to the clinical presentation announcement. 17-SEP-2026 07:30 AM ET